These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study. Pottegård A; Kristensen KB; Ernst MT; Johansen NB; Quartarolo P; Hallas J BMJ; 2018 Sep; 362():k3851. PubMed ID: 30209057 [TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. Lindenauer PK; Pekow P; Wang K; Gutierrez B; Benjamin EM JAMA; 2004 May; 291(17):2092-9. PubMed ID: 15126437 [TBL] [Abstract][Full Text] [Related]
14. Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study. Hallas J; Margulis AV; Pottegård A; Kristiansen NS; Atsma WJ; Appenteng K; de Vogel S; Kaye JA; Perez-Gutthann S; Arana A Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):612-619. PubMed ID: 29345103 [TBL] [Abstract][Full Text] [Related]
15. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register. Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824 [TBL] [Abstract][Full Text] [Related]
16. Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study. Alpérovitch A; Kurth T; Bertrand M; Ancelin ML; Helmer C; Debette S; Tzourio C BMJ; 2015 May; 350():h2335. PubMed ID: 25989805 [TBL] [Abstract][Full Text] [Related]
17. Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population. Larsen J; Andersen M; Kragstrup J; Gram LF Eur J Clin Pharmacol; 2001 Jul; 57(4):343-8. PubMed ID: 11549214 [TBL] [Abstract][Full Text] [Related]
19. Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy. Larsen J; Vaccheri A; Andersen M; Montanaro N; Bergman U Br J Clin Pharmacol; 2000 May; 49(5):463-71. PubMed ID: 10792204 [TBL] [Abstract][Full Text] [Related]